1.
|
10 p, 1.1 MB |
Monitoring and evaluation of breast cancer screening programmes : Selecting candidate performance indicators
/
Muratov, Sergei (McMaster University (Canadà)) ;
Canelo Aybar, Carlos Gilberto (Institut d'Investigació Biomèdica Sant Pau) ;
Tarride, Jean-Eric (McMaster University (Canadà)) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Dimitrova, Nadya (Joint Research Centre) ;
Borisch, Bettina (University of Geneva) ;
Castells, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Duffy, Stephen W. (Queen Mary University of London) ;
Fitzpatrick, Patricia (UCD School of Public Health) ;
Follmann, Markus (German Cancer Society) ;
Giordano, Livia (CPO-Piedmont - AOU Città della Salute e della Scienza) ;
Hofvind, Solveig (Cancer Registry of Norway) ;
Lebeau, Annette (University Medical Center Hamburg-Eppendorf) ;
Quinn, Cecily (Ordensklinikum Linz Elisabethinen) ;
Torresin, Alberto (ASST Grande Ospedale Metropolitano) ;
Vialli, Claudia (Joint Research Centre) ;
Siesling, Sabine (University of Twente) ;
Ponti, Antonio (CPO-Piedmont - AOU Città della Salute e della Scienza) ;
Giorgi Rossi, Paolo (Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia (Itàlia)) ;
Schünemann, Holger (McMaster University (Canadà)) ;
Nyström, Lennarth (Umeå University) ;
Broeders, Mireille (Radboud University Medical Center) ;
Autelitano, Mariangela ;
Colzani, Edoardo ;
Daneš, Jan ;
Gräwingholt, Axel ;
Ioannidou-Mouzaka, Lydia ;
Knox, Susan ;
Langendam, Miranda ;
McGarrigle, Helen ;
Pérez Gómez, Elsa ;
Van Engen, Ruben ;
Warman, Sue ;
Young, Kenneth ;
Van Landsveld-Verhoeven, Cary ;
Lerda, Donata ;
Saz-Parkinson, Zuleika ;
Parmelli, Elena ;
Janusch-Roi, Annett ;
Universitat Autònoma de Barcelona
In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. [...]
2020 - 10.1186/s12885-020-07289-z
BMC Cancer, Vol. 20 Núm. 1 (24 2020) , p. 795
|
|
2.
|
15 p, 1.7 MB |
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis
/
Graves, Jennifer S. (University of California San Diego) ;
Ganzetti, Marco (F. Hoffmann-La Roche Ltd, Basel) ;
Dondelinger, Frank (F. Hoffmann-La Roche Ltd, Basel) ;
Lipsmeier, Florian (F. Hoffmann-La Roche Ltd, Basel) ;
Belachew, Shibeshih (F. Hoffmann-La Roche Ltd, Basel) ;
Bernasconi, Corrado (F. Hoffmann-La Roche Ltd, Basel) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron) ;
Beek, Johan van (F. Hoffmann-La Roche Ltd, Basel) ;
Baker, Michael (F. Hoffmann-La Roche Ltd, Basel) ;
Gossens, Christian (F. Hoffmann-La Roche Ltd, Basel) ;
Lindemann, Michael (F. Hoffmann-La Roche Ltd, Basel) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Objective To validate the smartphone sensor-based Draw a Shape Test - a part of the Floodlight Proof-of-Concept app for remotely assessing multiple sclerosis-related upper extremity impairment by tracing six different shapes. [...]
2023 - 10.1002/acn3.51705
Annals of Clinical and Translational Neurology, Vol. 10 Núm. 2 (2023) , p. 166-180
|
|
3.
|
|
4.
|
16 p, 1.2 MB |
A RAD51 assay feasible in routine tumor samples calls inhibitor response beyond BRCA mutation
/
Castroviejo-Bermejo, Marta (Vall d'Hebron Institut d'Oncologia) ;
Cruz Zambrano, Cristina (Universitat Autònoma de Barcelona) ;
Llop-Guevara, Alba (Vall d'Hebron Institut d'Oncologia) ;
Gutiérrez-Enríquez, Sara (Vall d'Hebron Institut d'Oncologia) ;
Ducy, Mandy (CHUL. Genomics Center) ;
Ibrahim, Yasir Hussein (Vall d'Hebron Institut d'Oncologia) ;
Gris-Oliver, Albert (Vall d'Hebron Institut d'Oncologia) ;
Pellegrino, Benedetta (University Hospital of Parma) ;
Bruna, Alejandra (University of Cambridge) ;
Guzmán, Marta (Vall d'Hebron Institut d'Oncologia) ;
Rodríguez, Olga (Vall d'Hebron Institut d'Oncologia) ;
Grueso, Judit (Vall d'Hebron Institut d'Oncologia) ;
Bonache, Sandra (Vall d'Hebron Institut d'Oncologia) ;
Moles-Fernández, Alejandro (Vall d'Hebron Institut d'Oncologia) ;
Villacampa Javierre, Guillermo (Vall d'Hebron Institut d'Oncologia) ;
Viaplana, Cristina (Vall d'Hebron Institut d'Oncologia) ;
Gómez, Patricia (Vall d'Hebron Institut d'Oncologia) ;
Vidal, Marc (Vall d'Hebron Institut d'Oncologia) ;
Peg, Vicente (Instituto de Salud Carlos III) ;
Serres-Créixams, Xavier (Hospital Universitari Vall d'Hebron) ;
Dellaire, Graham (Dalhousie University) ;
Simard, Jacques (CHUL. Genomics Center) ;
Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ;
Rubio, Isabel T. (Hospital Universitari Vall d'Hebron) ;
Dientsmann, Rodrigo (Vall d'Hebron Institut d'Oncologia) ;
Barrett, J. Carl (AstraZeneca) ;
Caldas, Carlos (Cancer Research UK (CRUK) Cambridge Cancer Centre) ;
Baselga Torres, Josep 1959-2021 (Memorial Sloan Kettering Cancer Center) ;
Saura, Cristina (Vall d'Hebron Institut d'Oncologia) ;
Cortés, Javier (Vall d'Hebron Institut d'Oncologia) ;
Déas, Olivier (XenTech) ;
Jonkers, Jos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Masson, Jean-Yves (Laval University Cancer Research Center) ;
Cairo, Stefano (XenTech) ;
Judde, Jean-Gabriel (XenTech) ;
O'Connor, Mark J.. (AstraZeneca) ;
Diez, Orland (Vall d'Hebron Institut d'Oncologia) ;
Balmaña Gelpí, Judith (Vall d'Hebron Institut d'Oncologia) ;
Serra, Violeta (Instituto de Salud Carlos III) ;
Universitat Autònoma de Barcelona
Poly(-ribose) polymerase () inhibitors (i) are effective in cancers with defective homologous recombination repair (), including 1/2-related cancers. A test to identify additional -deficient tumors will help to extend their use in new indications. [...]
2018 - 10.15252/emmm.201809172
EMBO Molecular Medicine, Vol. 10 (october 2018)
|
|
5.
|
109 p, 2.7 MB |
Anatomical description of the coelomic cavity organs using radiography, ultrasonography and computed tomography in healthy veiled chameleons (Chamaeleo calyptratus) and panther chameleons (Furcifer pardalis)
/
Melero Jurado, Adrián ;
Martorell Montserrat, Jaume, dir.
El camaleó vetllat (Chamaeleo calyptratus) i el camaleó pantera (Furcifer pardalis) són dues de les espècies de camaleó més populars al món, i en conseqüència, dues de les que més freqüentment s'atenen a les consultes veterinàries. [...] El camaleón velado (Chamaeleo calyptratus) y el camaleón pantera (Furcifer pardalis) son dos de las especies de camaleón más populares en el mundo, y en consecuencia, dos de las que más frecuentemente se atienden en la consulta veterinaria. [...] Veiled chameleon (Chamaeleo calyptratus) and Panther chameleon (Furcifer pardalis) are the most popular chameleons over the world, and consequently, two of the most frequently species attended in veterinary practice. [...]
2020
|
|
6.
|
4 p, 1.3 MB |
Malignant Solitary Fibrous Tumour of the Breast Mimicking a Benign Tumor
/
Barco, Israel (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
González Minguez, Clarisa (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Vallejo, Elena (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Pessarrodona, Antoni (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Giménez, Nuria (Universitat Autònoma de Barcelona. Laboratori de Toxicologia) ;
García-Fernández, Antonio (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya))
Solitary fibrous tumour (SFT) of the breast is exceedingly uncommon. Radiological assessment usually shows benign features. We report on a case of malignant SFT of the breast, while emphasizing the need for additional immunostains to reach a definitive diagnosis. [...]
2019 - 10.1177/2632010X19868462
Clinical Pathology, Vol. 12 (august 2019) , p. 1-4
|
|
7.
|
21 p, 965.2 KB |
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
/
Suárez-Calvet, Marc (Ludwig-Maximilians-Universität München) ;
Capell, Anja (Ludwig-Maximilians-Universität München) ;
Araque Caballero, Miguel Ángel (Ludwig-Maximilians-Universität München) ;
Morenas-Rodríguez, Estrella (Universitat Autònoma de Barcelona) ;
Fellerer, Katrin (Ludwig-Maximilians-Universität München) ;
Franzmeier, Nicolai (Ludwig-Maximilians-Universität München) ;
Kleinberger, Gernot (Munich Cluster for Systems Neurology (SyNergy)) ;
Eren, Erden (Dokuz Eylul University, Turkey) ;
Deming, Yuetiva (Washington University School of Medicine) ;
Piccio, Laura (Washington University School of Medicine) ;
Karch, Celeste M. (Washington University School of Medicine) ;
Cruchaga, Carlos (Washington University School of Medicine) ;
Paumier, Katrina (Washington University School of Medicine) ;
Bateman, Randall J. (Washington University School of Medicine) ;
Fagan, Anne M. (Washington University School of Medicine) ;
Morris, John C. (Washington University School of Medicine) ;
Levin, Johannes (Ludwig-Maximilians-Universität München) ;
Danek, Adrian (Ludwig-Maximilians-Universität München) ;
Jucker, Mathias (University of Tübingen) ;
Masters, Colin L. (University of Melbourne) ;
Rossor, Martin N. (UCL Institute of Neurology (Regne Unit)) ;
Ringman, John M. (University of Southern California) ;
Shaw, Leslie M. (University of Pennsylvania) ;
Trojanowski, John Q.. (University of Pennsylvania) ;
Weiner, Michael (University of California at San Francisco) ;
Ewers, Michael (Ludwig-Maximilians-Universität München) ;
Haass, Christian (Munich Cluster for Systems Neurology (SyNergy))
Progranulin (PGRN) is predominantly expressed by microglia in the brain, and genetic and experimental evidence suggests a critical role in Alzheimer's disease (AD). We asked whether expression is changed in a disease severity-specific manner in . [...]
2018 - 10.15252/emmm.201809712
EMBO Molecular Medicine, Vol. 10 (november 2018)
|
|
8.
|
11 p, 519.1 KB |
2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
/
Suárez-Calvet, Marc (German Center for Neurodegenerative Diseases (DZNE) Munich) ;
Kleinberger, Gernot (Munich Cluster for Systems Neurology (SyNergy)) ;
Araque Caballero, Miguel Ángel (Ludwig-Maximilians-University Munich) ;
Brendel, Matthias (Ludwig-Maximilians-University Munich) ;
Rominger, Axel (Ludwig-Maximilians-University Munich) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ;
Gispert, Juan Domingo (Institut d'Investigació Biomèdica Sant Pau) ;
Sanchez-Valle, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Antonell, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rami Gonzalez, Lorena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Molinuevo, José Luis (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Brosseron, Frederic (German Center for Neurodegenerative Diseases (DZNE)) ;
Traschütz, Andreas (Universitätsklinikum Bonn) ;
Heneka, Michael T. (Universitätsklinikum Bonn) ;
Struyfs, Hanne (University Hospital Antwerp (Bèlgica)) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
Sleegers, Kristel (University of Antwerp. Institute Born-Bunge) ;
Van Broeckhoven, Christine (University of Antwerp. Institute Born-Bunge) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Nellgård, Bengt (Gothenburg University. Sahlgrenska Academy. Institute of Clinical Sciences) ;
Blennow, Kaj (The Sahlgrenska Academy at the University of Gothenburg. Institute of Neuroscience and Physiology) ;
Crispin, Alexander (Institute of Medical Informatics, Biometry, and Epidemiology) ;
Ewers, Michael (Ludwig-Maximilians-University Munich) ;
Haass, Christian (BioMedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich) ;
Universitat Autònoma de Barcelona
2 is an innate immune receptor expressed on the surface of microglia. Loss-of-function mutations of 2 are associated with increased risk of Alzheimer's disease (). 2 is a type-1 protein with an ectodomain that is proteolytically cleaved and released into the extracellular space as a soluble variant (2), which can be measured in the cerebrospinal fluid (). [...]
2016 - 10.15252/emmm.201506123
EMBO Molecular Medicine, Vol. 8 (march 2016) , p. 466-476
|
|
9.
|
15 p, 1.5 MB |
The Neuroanatomical Basis of Panic Disorder and Social Phobia in Schizophrenia : A Voxel Based Morphometric Study
/
Picado Rossi, Marisol (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Carmona Cañabate, Susana (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Hoekzema, Elseline (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Pailhez Vindual, Guillem (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Bergé Baquero, Daniel (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Mané, Anna (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Fauquet Ars, Jordi (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Hilferty, Joseph (Universitat de Barcelona. Departament de Filologia Anglesa i Alemanya) ;
Moreno, Ana (Fundación para la Investigación y la Docencia Maria Angustias Giménez) ;
Cortizo, Romina (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Vilarroya Oliver, Óscar (Institut Municipal d'Investigació Mèdica (Barcelona, Catalunya)) ;
Bulbena Vilarrasa, Antonio (Institut Hospital del Mar d'Investigacions Mèdiques)
Objective: It is known that there is a high prevalence of certain anxiety disorders among schizophrenic patients, especially panic disorder and social phobia. However, the neural underpinnings of the comorbidity of such anxiety disorders and schizophrenia remain unclear. [...]
2015 - 10.1371/journal.pone.0119847
PloS one, Vol. 10, Issue 3 (March 2015) , p.e0119847
|
|
10.
|
|